Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Investment in securities market are subject to market risks. Read all the related documents carefully before investing

We're Extremely Bullish on These
3 Stocks Built for India's Next Growth Wave


See Full Details

**Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
**By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster
covering exciting investing ideas and opportunities in India.

AD
  • Home
  • Views On News
  • May 15, 2026 - Rupee Hits Record Low: 4 Export-Focused Stocks to Watch

Rupee Hits Record Low: 4 Export-Focused Stocks to Watch

May 15, 2026

Rupee Hits Record Low: 4 Export-Focused Stocks to WatchImage source: Rasi Bhadramani/www.istockphoto.com

The Indian rupee has had a rough 2026. It's now the worst-performing currency in Asia this year, down over 6% year-to-date, and the pressure isn't letting up.

The rupee hit an all-time low of Rs 95.96 to the dollar during intraday trade on Thursday, before recovering slightly to around Rs 95.8 on Friday.

This week alone, it's lost 1.4%, and it set fresh record lows in every session from Tuesday through Thursday.

The main culprit?

Oil.

Crude prices have been surging, and Indian oil marketing companies are buying dollars in bulk to pay for imports, keeping constant pressure on the rupee.

India imports roughly 90% of its oil needs and about half its gas requirements, which makes the currency especially exposed if the Iran conflict drags on and keeps energy markets on edge.

Rising import costs are also widening India's trade deficit, adding another layer of strain on the external account.

That said, there's a silver lining for one corner of the market. With the rupee weak, Indian exporters are cashing in, every dollar they earn translates into significantly more rupees than it did at the start of the year.

Here are the stocks worth watching as the rupee continues to slide.

#1 Aurobindo Pharma

First on the list is Aurobindo Pharma.

Aurobindo Pharma is a Hyderabad-based integrated global pharmaceutical company engaged in the development, manufacturing, and commercialisation of APIs, generics, specialty products, injectables, biosimilars, vaccines, peptides, and metered dose inhalers.

The company operates in more than 150 countries, making it one of India's major contributors to the global pharmaceutical industry.

It emerged as the third-largest Indian pharmaceutical company by revenue in FY25. In the US, it holds the position of the largest generic pharma company by prescriptions dispensed.

In Europe, the company is a leading player with operations across 10 countries, including France, Spain, Portugal, Italy, Germany, the UK, the Netherlands, Belgium, and Poland. The company's footprint covers 75% of the European generic market with a large portfolio of marketed products.

According to its Q3 FY26 earnings presentation, the company derives a substantial share of its revenue from international markets.

Aurobindo Pharma

The US, Europe, and Growth Markets together contributed nearly 84.5% of total revenue from operations during the quarter.

These regions generated around Rs 73.1 billion (bn) out of the company's total revenue of Rs 86.5 bn, highlighting its strong global business exposure, particularly in the US and European markets.

This makes Aurobindo Pharma a stock to watch amid rupee depreciation, as a weaker rupee generally benefits export-focused companies by boosting realizations from overseas revenue.

On the financial front, over the past three years the company's revenue has seen a growth of 10.6%, meanwhile, net profit grew at a CAGR of 9.6%.

The company's three-year average ROE and ROCE stand at 9.5% and 13.6%.

Aurobindo Pharma's Financial Snapshot (FY23-25)

Year 2023 2024 2025
Revenue (Rs in m) 2,48,554 2,90,019 3,17,237
Revenue Growth (%) 6 16.7 9.4
Net Profit (Rs in m) 19,277 31,690 34,836
Net profit margin (%) 7.8 10.9 11
Return on equity (%) 7.2 10.6 10.7
Return on capital employed (%) 10 14.6 16.1
Source: Equitymaster

For more details, see the AUROBINDO PHARMA company fact sheet and quarterly results.

Want To Read The Full Article?

Enter your email to continue reading on Equitymaster.

Important: We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
By submitting your email address, you also sign up for Profit Hunter, a daily newsletter from Equitymaster covering exciting investing ideas and opportunities in India.

Equitymaster requests your view! Post a comment on "Rupee Hits Record Low: 4 Export-Focused Stocks to Watch". Click here!